|Articles|April 19, 2012

The Column-04-19-2012
Volume 7
Issue 8

Strategies for Rapid Chiral HPLC Method Development for Pharmaceutical Analysis

Author(s)Kelly Ke Zhang, Midco Chi-Ying Tsang

Automated column and mobile phase screening is the current trend in the pharmaceutical industry to develop chiral methods. This study presents comprehensive strategies for automated rapid chiral HPLC method development including normal-phase, reversed-phase and polar organic phase separation modes.

Click here for the full article in The Column

Articles in this issue

over 14 years ago

Article

Oil spill

over 14 years ago

Article

Autism biomarkers

over 14 years ago

Article

High Throughput Microchromatography

over 14 years ago

Article

Ultra-High Resolution Chromatography Using 500 mm UHPLC Columns for Detection Of Hidden Sample Components

over 14 years ago

Article

Organic separation

over 14 years ago

Article

Biofuel analysis

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Related to this article

October 16th, 2026

Conversations with Michael Dong: Overcoming Challenges with Reversed-Phase Chromatography in Drug Analysis

In this fifth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor discusses how to overcome challenges with reversed-phase chromatography in drug analysis.

October 16th, 2026

LC–MS/MS Finds Diabetic Kidney Disease Markers

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) and microbiome data reveal kidney markers of diabetic disease.

October 16th, 2026

UHPLC-MS/MS Tracks Maresin1 in Heatstroke Hearts

Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) shows Maresin1 drops in heatstroke and may protect the heart.

October 16th, 2026

Best of the Week: From Green Affinity Chromatography to AI and GLP-1 Peptide Robustness

This week on Chromatography Online, leading experts shared practical insights with LCGC International on sustainable affinity methods, siRNA impurity profiling, nontarget screening, peptide tech transfer, and AI in separation science.

October 15th, 2026

LC–MS Probes Link Between Artificial Sweeteners and Breast Cancer

Liquid chromatography–mass spectrometry (LC–MS) was used to determine if there is a link between artificial sweeteners and breast cancer.

October 15th, 2026

Chiral GC–MS Tracks Linalool in Blueberry Juice

Chiral gas chromatography–mass spectrometry (GC–MS) shows how heat and storage alter linalool in blueberry juice.

Anneli Kruve, Stockholm University; RAFA 2026

October 15th, 2026

Prioritizing Unknowns in Nontarget Screening of Food Samples

Anneli Kruve reports that toxicity predictions from MS2-derived molecular fingerprints outperform spectral-similarity methods in nontarget screening of food.

October 14th, 2026

Conversations with Michael Dong: Buffers for Mobile Phase A in Pharmaceutical Analysis

In this fourth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor explains why buffers are most often used in Mobile Phase A in high-pressure liquid chromatography of pharmaceuticals.

Strategies for Rapid Chiral HPLC Method Development for Pharmaceutical Analysis

Articles in this issue

Related to this article

Trending on LCGC International

Prioritizing Unknowns in Nontarget Screening of Food Samples

Jan Christensen on Quantitative Non-Targeted Screening

Conversations with Michael Dong: Overcoming Challenges with Reversed-Phase Chromatography in Drug Analysis

Conversations with Michael Dong: Buffers for Mobile Phase A in Pharmaceutical Analysis

The Future of GLP-1 Peptide Analysis: AI, Automation, and the Scientist's Role